Please use this identifier to cite or link to this item:
|Title:||The Association of Serum 25-Hydroxyvitamin D With Biomarkers of Hemolysis in Pediatric Patients With Sickle Cell Disease|
|Authors:||Adegoke, Samuel Ademola [UNIFESP]|
Braga, Josefina Aparecida Pellegrini [UNIFESP]
Adekile, Adekunle D.
Figueiredo, Maria Stella [UNIFESP]
pediatric sickle cell disease
|Publisher:||Lippincott Williams & Wilkins|
|Citation:||Journal Of Pediatric Hematology Oncology. Philadelphia, v. 40, n. 2, p. 159-162, 2018.|
|Abstract:||Although vitamin D deficiency (VDD) has been linked to anemia among sickle cell disease (SCD), its relationship with hemolysis is unclear. Serum 25-hydroxyvitamin D and biomarkers of hemolysis (hemoglobin [Hb]/hematocrit, reticulocyte percentage, absolute reticulocyte, and lactate dehydrogenase [LDH] levels) in 36 hydroxyurea-naive SCD children were quantified. Correlations were significantly positive with Hb/hematocrit (r=0.40, P=0.017|
r=0.45, P=0.006, respectively)
inverse with reticulocyte percentage, absolute reticulocyte, and LDH (r=-0.44, P=0.008
r=-0.45, P=0.007, respectively). In VDD groups, Hb was lower (P=0.014), reticulocyte counts and LDH were higher (P=0.047 and 0.003, respectively). Serum 25-hydroxyvitamin D correlated with biomarkers of hemolysis in SCD and VDD may play a role in SCD pathogenesis.
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.